會(huì)員.png)
5當(dāng)前位置：武漢原生原代生物醫(yī)藥科技有限公司>>成功案例
您好, 歡迎來(lái)到化工儀器網(wǎng)！ 登錄| 免費(fèi)注冊(cè)| 產(chǎn)品展廳| 收藏商鋪|
您好, 歡迎來(lái)到化工儀器網(wǎng)！ 登錄| 免費(fèi)注冊(cè)| 產(chǎn)品展廳| 收藏商鋪|
當(dāng)前位置：武漢原生原代生物醫(yī)藥科技有限公司>>成功案例
當(dāng)前位置：武漢原生原代生物醫(yī)藥科技有限公司>>成功案例
賀首都醫(yī)科大學(xué)附屬北京佑安醫(yī)院等單位應(yīng)用PriCells產(chǎn)品/技術(shù)服務(wù)發(fā)表文章
Comparison of the regulation of β-catenin signaling by type I, type II and type III interferons in hepatocellularcarcinoma cells.
PLoS One. 2012;7(10):e47040. doi: 10.1371/journal.pone.0047040. Epub 2012 Oct 4.
Wei Li1, Xiaojie Huang1, Hongfei Tong2, Yuxuan Wang4, Tong Zhang1, Wen Wang1, Lili Dai1,Tongzeng Li1, Shengzhang Lin3*, Hao Wu1*
1Department of Infectious Diseases, Beijing You’an Hospital, Capital Medical University, Beijing, China,
2Department of General Surgery, Second Affiliated Hospital,Wenzhou Medical College, Wenzhou, Zhejiang, China,
3Department of Hepato-biliary-pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine,Hangzhou, Zhejiang, China,
4Materials Science and Engineering Program, State University of New York at Binghamton, Binghamton, New York, United States of America
The hepatocellular carcinoma cell lines, PriCells, Wuhan, China
請(qǐng)輸入賬號(hào)
請(qǐng)輸入密碼
請(qǐng)輸驗(yàn)證碼
以上信息由企業(yè)自行提供，信息內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé)，化工儀器網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。
溫馨提示：為規(guī)避購(gòu)買(mǎi)風(fēng)險(xiǎn)，建議您在購(gòu)買(mǎi)產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。